研究・業績

2018年

  1. Doi H, Morikawa K, Kanto T. Immunity against hepatitis B virus and HBV vaccines. eLS 2018 Jan. a0026254

  2. Osawa Y, Kojika E, Hayashi Y, Kimura M, Nishikawa K, Yoshio S, Doi H, Kanto T, Kimura K   Tumor necrosis factor-α-mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice. Hepatology Communication 2018 Feb 13;2(4):407-420. 内容紹介

  3. Doi H, Hayashi E, Arai J, Tojo M, Morikawa K, Eguchi J, Ito T, Kanto T, Kaplan DE, Yoshida H
    Advanced cirrhosis drives enhanced B-cell differentiation resulting in hyperglobulinemia. J Gastroenterol Hepatol. 2018 (in press)

  4. Shimagaki T, Yoshizumi T, Harimoto N, Yoshio S, Naito Y, Yamamoto Y, Ochiya T, Yoshida Y, Kanto T, Maehara Y. MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection. Hepatol Res. 2018 Mar;48(4):313-321.

  5. Yoshio S, Mano Y, Doi H, Shoji H, Shimagaki T, Sakamoto Y, Kawai H, Matsuda M, Mori T, Osawa Y, Korenaga M, Sugiyama M, Mizokami M, Mita E, Katayama K, Tanaka J, and Kanto T. Cytokine and chemokine signatures associated with hepatitis B surface antigen loss in hepatitis B patients.JCI insight. 2018; 3(20); e122268内容紹介

共著論文

  1. Suzuki T, Okamoto T, Katoh H, Sugiyama Y, Kusakabe S, Tokunaga M, Hirano J, Miyata Y, Fukuhara T, Ikawa M, Satoh T, Yoshio S, Suzuki R, Saijo M, Huang DCS, Kanto T, Akira S, Matsuura Y. Infection with flaviviruses requires BCLXL for cell survival. PLoS Pathog 27; 14(9): e1007299

  2. Kawashima T, Ikari N, Watanabe Y, Kubota Y, Yoshio S, Kanto T, Motohashi S, Shimojo N, Tsuji NM. Double-Stranded RNA Derived from Lactic Acid Bacteria Augments Th1 Immunity via Interferon-β from Human Dendritic Cells. Front Immunol 9:27, 2018

国立国際医療研究センター
肝炎・免疫研究センター
肝疾患研究部

〒272-8516 千葉県市川市国府台1-7-1
TEL 047-372-3501/FAX 047-375-4766